February 26, 2018

NRG Oncology Broadcast archives are accessible from our website at any time. Please bookmark this link for your convenience.

AMENDMENTS AND UPDATES
HEAD & NECK
NRG-HN002 Reminder for sites in Canada: Amendment 3 was reviewed by Health Canada as a CTA-Notification. Health Canada does not issue acknowledgement letters for this type of submission. Sites in Canada may proceed with IRB/REB submission.

RTOG 0920: Amendment 11 was reviewed by Health Canada as a CTA-Notification. Health Canada does not issue acknowledgement letters for this type of submission. Sites in Canada may proceed with IRB/REB submission.


OTHER PROTOCOL NOTICES
1. BREAST
NSABP B-51/RTOG 1304: E-mail Blast (posted to CTSU)

NRG-BR003: E-mail Blast (posted to CTSU)

2. LUNG
NRG-LU002: The current Spanish-translated consent form is now available on the CTSU website.

3. VTOC TRAINING
The VTOC Webinar Training Series schedule and registration is available for NRG Oncology Research Associates working on RTOG 0924, RTOG 0920, NRG-HN001, NRG-HN002, NRG-CC003, and NRG-CC004. Space is limited so register now and reserve your seat.  The next webinar training is scheduled for March 14, 2018.

 

DRUG SAFETY UPDATES
Safety updates have been issued for NSABP legacy studies. For details, please see the NSABP E-mail Distributions page and CTSU.

Safety updates have been issued for the following NRG Oncology studies:
- Atezolimumab:  NRG-GI004, NRG-GY009
- Ipilimumab:  NRG-BN002, NRG-GY003
- Nivolumab:  NRG-BN002, NRG-GY002, NRG-GY003

  • For NRG-GI004 and NRG-GY009 safety reports, please see CTSU
  • For NRG-GY002 and NRG-GY003 safety reports, please see the protocol page on NRG Oncology.
  • For NRG-BN002 safety reports, please see the protocol page on NRG Oncology.

NRG Oncology General Session Slides
Slides from the NRG Oncology Semiannual Meeting General Session are now available on the website. Slides include updates on the NRG Oncology grant, leadership changes, research strategy, biospecimen bank, membership committee, publications committee, NCORP, SDMC, and NCI informed consent template revisions.

NRG Oncology is pleased to report the scientific articles and abstracts that have appeared or have been presented during the previous week. This publications report includes links, when available, to the article, PubMed abstract, or association abstract.

JOURNAL ARTICLES
Blumenthal DT, Won M, Mehta MP, Gilbert MR, Brown PD, Bokstein F, Brachman DG,Werner-Wasik M, Hunter GK, Valeinis E, Hopkins K, Souhami L, Howard SP, Lieberman FS, Shrieve DC, Wendland MM, Robinson CG, Zhang P, Corn BW. Short delay in initiation of radiotherapy for patients with glioblastoma- effect of concurrent chemotherapy: a secondary analysis from the NRG Oncology/Radiation Therapy Oncology Group (RTOG) database. Neuro Oncol. 2018 Feb 15. doi: 10.1093/neuonc/noy017. [Epub ahead of print] PubMed PMID: 29462493. Read more

Mamounas EP, Tang G, Paik S, Baehner FL, Liu Q, Jeong JH, Kim SR, Butler SM, Jamshidian F, Cherbavaz DB, Sing AP, Shak S, Julian TB, Lembersky BC, Wickerham DL, Costantino JP, Wolmark N. 21-Gene Recurrence Score for prognosis and prediction of taxane benefit after adjuvant chemotherapy plus endocrine therapy: results from NSABP B-28/NRG Oncology. Breast Cancer Res Treat. 2018 Feb;168(1):69-77. doi: 10.1007/s10549-017-4550-8. Epub 2017 Nov 11. PubMed PMID: 29128898. Read more

Wapnir IL, Price KN, Anderson SJ, Robidoux A, Martín M, Nortier JWR, Paterson AHG, Rimawi MF, Láng I, Baena-Cañada JM, Thürlimann B, Mamounas EP, Geyer CE Jr, Gelber S, Coates AS, Gelber RD, Rastogi P, Regan MM, Wolmark N, Aebi S; International Breast Cancer Study Group; NRG Oncology, GEICAM Spanish Breast Cancer Group, BOOG Dutch Breast Cancer Trialists' Group; Breast International Group. Efficacy of Chemotherapy for ER-Negative and ER-Positive Isolated Locoregional Recurrence of Breast Cancer: Final Analysis of the CALOR Trial. J Clin Oncol. 2018 Feb 14:JCO2017765719. doi: 10.1200/JCO.2017.76.5719. [Epub ahead of print] PubMed PMID: 29443653. Read more

PUBLICATIONS REMINDERS
Please note the following upcoming meeting and abstract submission deadline dates

Upcoming Meetings
Society of Gynecologic Oncology (SGO); Mar 24-27, 2018; New Orleans, LA

Society of Surgical Oncology (SSO); Mar 21-24, 2018; Chicago, IL

St. Gallen GI Cancer Conference; Mar 15-17, 2018; St Gallen, Switzerland

United States and Canadian Academy of Pathology (USCAP); Mar 17-23, 2018; Vancouver, BC

Upcoming Abstract Submission Deadlines
American Association of Physicists in Medicine (AAPM); Jul 29 - Aug 2, 2018; Nashville, TN; due to publications committee Feb 28, 2018; meeting abstracts submission deadline Mar 8, 2018

American Society of Clinical Oncology (ASCO); Jun 1-5, 2018; Chicago, IL; Late-breaking Mar 15, 2018

American Society for Radiation Oncology (ASTRO); Oct 21-24, 2018; San Diego, CA; Late-breaking Aug 1, 2018

College of American Pathologists (CAP); Oct 20-24, Chicago, IL; meeting abstracts submission deadline Mar 9, 2018

Multinational Association of Supportive Care in Cancer (MASCC); Jun 28-30, 2018; Vienna, Austria; Late-breaking due Apr 20, 2018



 


NRG Oncology is proud to be an active participant of #CancerMoonShot.

View this email in your browser
You are receiving this email because of your relationship with NRG Oncology. Please reconfirm your interest in receiving emails from us. If you do not wish to receive any more emails, you can unsubscribe here.

Four Penn Center 1600 JFK Blvd. Suite1020 , Philadelphia, PA, 19103


Update Profile/Email Address